Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Orhy.
Doubt the share price will move when we start clinical trial - as this bb keeps reiterating we are "now clinical"
Hopefully price will rise on any potential positive results of the trial and hopefully on any talk of JV or partner agreement to yhe disgust of Vlad.
JHFH.
We will have to agree to disagree (either politely or not).
If a company has a solid product,solid management,solid pathway to progression then they should be able to steamroller the practice of shorting and trading to make it impossible to gain from.
It would seem Vlad and prevail have not managed to accomplish what you have espoused for months of finding JV's,investors and collaborations with the run up to your holy grail of FDA CH.
You say you are "sick to death defending Vlad",probably, the same annoyance many have when they have to criticise him.
Marmite comes to mind.
JHFH.
I think you suffer from some form of Stockholm syndrome.
Your defence that Vlad and hemo are overpowered by stu is laughable.
I agree shorters are the bain of small cap companies but if they are viably strong,funded,well managed and garner momentum then shorters shouldn't be able to gain traction.
But guess what.........
AREAL.
Sorry to say I think your post is a little misguided.
You say Vlad will do "anything to get the product to market" - think history suggests he will only do this if he is in control and leads to missed opportunities,ever reducing placings and allows the company to be simply traded.
You also state he is not " money orientated" - which may be true,however being cushioned by an exceptionally well paid finance package and share scheme might make his stance easier.
Think there is a lot of nitpicking about timings and fault.
I think what could be agreed is that this share is in a hole with little hope.
It's hard to trade because of the spread,sentiment is poor and any fundamental newsflow looks unlikely.
Haywain for hemo!!.
Following on from yesterday's excellent RNS.
I am now interested to see Vlad's psyche going forward.
I keep reading eye watering figures of pharma takeovers.With the huge huge potential in the science and the still relatively low market cap,you would like to think Hemo would start to be appear on the radar much larger pharma.
Vlad has more than proven his stock a lead scientist but is he prepared to relinquish power and development pathway according to Prevail's input and when any offers of takeover or JV appear.
They are still nicer problems and concerns than I have had prior to Friday.